SUMMARY
PURPOSE/OBJECTIVE
• Is there enough scientific evidence to support separate limits for oAs and iAs?
• Do we have adequate analytical methods to distinguish between the two forms?
BACKGROUND

Arsenic and its Derivatives
o Arsenic occurs naturally in the environment as iAs (-3, +3, +5) and oAs forms o Examples of iAs forms (As-trioxide, sodium arsenite, As-trichloride, Aspentoxide) o Examples of oAs forms (arsanilic acid, methylarsonic acid, arsenobetaine) o Arsenic is also present in environment from pesticide use and industrial activities o Arsenic is present in soil (potential for plant uptake), water, marine animals and marine plants (*kelp/seaweed where oAs > iAs)
Analytical Methodology
o AAS -atomic absorption spectrophotometry is a common method for total As o Chemical difference between iAS and oAS species makes the separation of the two possible prior to analysis (e.g. by complexation with chloride ions to form AsCl 3 followed by distillation) o Data suggests the order of toxic potential for As compounds as follows:
o Chronic exposure: various adverse health effects on organs (i.e. kidney, liver, blood, skin) and organ systems o Acute exposure: data is available on toxic effects of oAs metabolite exposure in animals (e.g. depressed motility and respiration, irritability, ataxia 1 and convulsions in mice) 3.6. Exposure o For the purpose of estimating population exposure, it is generally assumed that most of As in air, water, and soil is inorganic, and the majority of As in plant and animal matrices is organic o Environmental exposure depends on history of land use and proximity to industrial sources:
o Dietary exposure from food and water: Total As: 1-1000 µg/day in U.S., 38.1 µg/day in Canada (overall, 20-40% of total As is iAs) iAs: 8.3 -14 µg/day in U.S., 4.8 -12.7 µg/day in Canada Drinking water (DW): average exposure to iAs from DW is 5µg/day, or higher from contaminated sites; health effects associated with oral exposure to iAs are more likely to result from contaminated DW than food Food: grains, meat, *seafood (critical commodity at ~90% of dietary As, but contributing mostly oAs)
Seafood consumption has not been linked with As toxicity in humans or other mammals; seafood has low levels of toxic iAs compounds (1-3% of total As) Estimated dietary consumption of fish & seafood varies among countries: Total As: <10 to 200 µg/day oAs: > 1000 µg/day in populations dependent on fishing for food iAs: 10-20 µg/day Kelp/seaweed contains mostly oAs (arsenosugars), except hijiki seaweed. Arsenic content of various seaweed types (brown, red, and green) are provided in IAS (Table 2) : Total As: brown > red > green iAs: brown > red > green
Measuring human exposure to As using total urinary As as a biomarker is problematic (i.e. confounded by high [oAs] in seafood, food preparation method, and bioavailability of As species).
o Exposure from therapeutic products: Historically used as a therapeutic drug for various ailments (Fowler's solution, As-triiodide, iAs preparations, oAs antibiotics such as Salvarsan).
o Exposure and speciation: Arsenic speciation in plants is influenced by many factors. In turn, As speciation determines exposure, uptake/absorption, toxicodynamics and bioavailability. Bioavailability data is critical to estimating risk, however research is directed towards assessing exposure to total As.
Current Limits of Exposure
See Table 3 in IAS.
Inorganic As tolerance limit
ATSDR (2007) o TDIs of ~2 µg/day, and medicinal herbs found to contain mean [As] of 2 µg/g, and commercial preparation further reduces [As] by 100-1000X o exposure calculations using iAs levels found in common marine algal supplements, and typical dosage levels, indicate affected NHPs would meet new limit (Appendix I of IAS)
Organic As tolerance limit ATSDR (2007) Chronic MRL for DMA of 20 µg DMA/kg/day is a conservative, practicable limit considering: o oAs derivatives are much less toxic than iAs, but not completely innocuous o assuming ~100% of arsenosugars and arsenolipids may be metabolized to DMA (major metabolite) o exposure calculations using oAs levels found in common marine algal supplements, and typical dosage levels, indicate affected NHPs would meet new limit (Appendix I of IAS)
Total As tolerance limit Current NHPD tolerance limit for total As in finished NHPs is 0.14 µg/kg bw/day; calculated by dividing NSF limit (0.01 mg/day) by 70 kg.
This limit is very conservative (<50% of ATSDR chronic MRL for iAs, 7% of JECFA pTDI).
Tolerance limit for total As appears adequate to mitigate any risk to health, considering: -most of daily As intake is from dietary sources (food and water) rather than dietary supplements -most of health risk is associated with iAs exposure OPTIONS ANALYSIS Option#1: maintain current limit of 0.14 µg/kg bw/day for total As (considering dosage and subpopulations) with no distinction between iAs and oAs Option #2: maintain current limit of 0.14 µg/kg bw/day for total As; if total As in the NHP exceeds limit (considering dosage and subpopulations), company may conduct additional testing to demonstrate level of iAS consumed in product would be <0.03 µg/kg bw/day and level of oAs consumed in product would be <20 µg/kg bw/day.
RECOMMENDATION
Option #2.
DECISION
Option #2 was supported by Health Canada's Marketed Health Products Directorate and Health Products and Food Branch Inspectorate, the NHPD Expert Advisory Committee, with input from The United States Pharmacopoeia (additional methodologies).
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